FDA approves For Eisais Anticancer Agent Lenvima In Combination With Everolimus as Treatment For...
Eisai Co Ltd announced that its U.S. subsidiary Eisai Inc. has received approval from the...
AstraZeneca reports positive results from benralizumab phase III programme
AstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated...
Pfizers Newest Rheumatoid Arthritis (RA) Survey Finds a Disconnect in Doctor-Patient Communication
Pfizer announced results from the second phase of its global RA surveys, which assessed the...
AstraZeneca announces positive results from benralizumab phase III programme in severe asthma
AstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated...
Otsuka Holdings Announces Collaboration with ReCor Medical for Commercialization of ReCor Medical’s Ultrasound Renal...
Otsuka Holdings Co Ltd announced the signing of a development and commercialization agreement with ReCor...
Biogen Announces Collaboration with University of Pennsylvania on Multiple Gene Therapy Programs
Visionary, up to $2 billion multi-year alliance to focus on development of new gene...
Immunosup pressant CellCept Obtained Approval for Additional Indication of “Lupus Nephritis”
Chugai Pharmaceutical Co Ltd. announced that it obtained a supplemental approval from the Japanese Ministry...
Chugai Pharmaceutical Co Ltd. to Take Part in “Relay for Life Japan” Using “3D...
Chugai Pharmaceutical Co Ltd announced that its co-sponsorship of “Relay for Life Japan” (Organizer: Japan...
Pfizer reports Results From Two Phase 3 TRUMENBA (Meningococcal Group B Vaccine) Studies At...
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal...
Pfizer Announces Results From Two Phase 3 TRUMENBA Studies At The European Society...
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal...
